Cargando…
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
BACKGROUND: TRAF3, a new tumor suppressor identified in human non-Hodgkin lymphoma (NHL) and multiple myeloma (MM), induces PKCδ nuclear translocation in B cells. The present study aimed to evaluate the therapeutic potential of two PKCδ activators, N-Benzyladriamycin-14-valerate (AD 198) and ingenol...
Autores principales: | Edwards, Shanique K E, Moore, Carissa R, Liu, Yan, Grewal, Sukhdeep, Covey, Lori R, Xie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853153/ https://www.ncbi.nlm.nih.gov/pubmed/24131623 http://dx.doi.org/10.1186/1471-2407-13-481 |
Ejemplares similares
-
N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
por: Ganapathi, R., et al.
Publicado: (1989) -
Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms
por: Moore, Carissa R, et al.
Publicado: (2015) -
Ultrasound-Assisted Esterification of Valeric Acid to Alkyl Valerates Promoted by Biosilicified Lipases
por: Cebrián-García, Soledad, et al.
Publicado: (2018) -
Brovalol, a New Valeric
Publicado: (1909) -
Tuneable Acidity in Fluorinated Al-SBA-15 Materials for the Esterification of Valeric Acid to Alkyl Valerates
por: Blanco-Sánchez, Miguel, et al.
Publicado: (2020)